GENERIC NAME OF THE MEDICINAL PRODUCT:
2) Colistimethate Sodium for Injection IP 1MIU
3) Colistimethate Sodium for Injection IP 2MIU
4) Colistimethate Sodium for Injection IP 3MIU
5) Colistimethate Sodium for Injection IP 4.5MIU
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Colistimethate Sodium IP
5,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10ml Sterile Water for Injection IP.
As sterile powder for reconstitution
Excipients............................q.s.
Water for injection IP 10 ml
2) Each vial contains:
Colistimethate Sodium IP
1,50,000 IU
(1.2 International Units)
The Pack also contains one FFS Ampoule of 10ml Sterile Water for Injection IP
as sterile powder for reconstitution Excipients.....................................q.s.
Water for Injection IP 10 ml.
3) Each vial contains:
Colistimethate Sodium IP
20,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml Sterile Water for Injection IP.
As sterile powder for reconstitution Excipients................................ q.s.
For water for injection IP 10 ml.
4) Each vial contains:
Colistimethate Sodium IP 30,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml
Sterile Water For Injection IP.
As sterile powder for reconstitution
Excipients.......................... q.s.
Water for Injection IP 10 mL.
5) Each vial contains:
Colistimethate Sodium IP
45,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml Sterile Water For Injection IP.
As sterile powder for reconstitution Excipients.................................. q.s.
Water for Injection IP 10 ml.
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
DOSAGE: As directed by the physician. Use reconstituted Solution immediately.
Colistimethate Sodium for Injection I.P. 2 MIU Technical Specification:
| Product Name: | Colistimethate Sodium for Injection I.P. 2 MIU |
| Brand Name: | COLISTIN |
| Strength: | 0.5MIU ,1MIU, 2MIU , 3MIU , 4.5MIU |
| Dosage Form: | Lyophilized Powder for Injection (Sterile) |
| Packing: | 1 Single Dose Vial + WFI Tray |
| Route of Administration: | For I.V. use only |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) , SMPC |
| Documents: | COA, MOA, Product Permission, Stability Studies, GMP |
| Therapeutic use: | Anti-Infective, Antibacterial, Antibiotics (polymyxin) |
| Indication: | Colistimethate injection is used to treat certain infections caused by bacteria. Colistimethate injection is in a class of medications called antibiotics. It works by killing bacteria. |
| Storage: | Store below 25°C. Protect from light and moisture. Do not freeze. |
GENERIC NAME OF MEDICINAL PRODUCT:
1) Colistimethate Sodium for Injection IP 0.5MIU
2) Colistimethate Sodium for Injection IP 1MIU
3) Colistimethate Sodium for Injection IP 2MIU
4) Colistimethate Sodium for Injection IP 3MIU
5) Colistimethate Sodium for Injection IP 4.5MIU
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1) Each vial contains:
Colistimethate Sodium IP
5,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10ml Sterile Water for Injection IP.
As sterile powder for reconstitution
Excipients……………………….q.s.
Water for injection IP 10 ml
2) Each vial contains:
Colistimethate Sodium IP
1,50,000 IU
(1.2 International Units)
The Pack also contains one FFS Ampoule
of 10ml Sterile Water for Injection IP
as sterile powder for reconstitution
Excipients……………………………….q.s.
Water for Injection IP 10 ml.
3) Each vial contains:
Colistimethate Sodium IP
20,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml Sterile Water for Injection IP.
As sterile powder for reconstitution
Excipients………………………….. q.s.
For water for injection IP 10 ml.
4) Each vial contains:
Colistimethate Sodium IP
30,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml Sterile Water For Injection IP.
As sterile powder for reconstitution
Excipients…………………….. q.s.
Water for Injection IP 10 mL.
5) Each vial contains:
Colistimethate Sodium IP
45,00,000 IU
(IU: International Units)
This Pack Also Contains one FFS Ampoule of 10 ml Sterile Water For Injection IP.
As sterile powder for reconstitution
Excipients……………………………. q.s.
Water for Injection IP 10 ml.
THERAPEUTIC INDICATION:
Colistimethate injection is used to treat certain infections caused by bacteria. Colistimethate injection is in a class of medications called antibiotics. It works by killing bacteria.
CAUTION AND SCHEDULE:
Caution: If any foreign particle is visible in the vial after dissolving the contents, please do not use the solution.
SCHEDULE H PRESCRIPTION DRUG – CAUTION: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE AND DOSAGE:
STORAGE: Store below 25°C. Protect from light & moisture. Keep all medicines out of reach of children.
DOSAGE: As directed by the physician. Use reconstituted Solution immediately.
Colistimethate Sodium for Injection I.P. 2 MIU Manufacturer Supplier in India – Why Taj Medico is the Best Exporter for Global Buyers
Introduction to Colistimethate Sodium for Injection I.P. 2 MIU
Colistimethate Sodium for Injection I.P. 2 MIU is a sterile injectable antibiotic used in hospital and critical-care settings for serious bacterial infections, particularly infections caused by susceptible multidrug-resistant Gram-negative bacteria. It is a prodrug of colistin and is generally reserved for situations where other antibacterial options may be unsuitable. Because antimicrobial resistance continues to create significant challenges for healthcare systems worldwide, dependable access to quality-assured critical-care antibiotics remains important for hospitals, healthcare distributors, and pharmaceutical procurement organizations.
As a Colistimethate Sodium for Injection I.P. 2 MIU manufacturer in India, Taj Medico focuses on supplying pharmaceutical products for domestic and international markets. The product is intended for administration by qualified healthcare professionals, with dosage and treatment duration determined according to the patient’s infection, clinical condition, renal function, and applicable medical guidelines. It should not be self-administered.
Colistimethate Sodium for Injection I.P. 2 MIU Uses and Pharmaceutical Importance
Colistimethate sodium is an antibacterial medicine associated with the treatment of serious infections caused by susceptible Gram-negative organisms. In clinical practice, its use may be considered for severe infections when resistance patterns limit alternative therapies. Because colistimethate can have important renal and neurological safety considerations, appropriate medical supervision and monitoring are essential.
For international buyers, sourcing a consistent sterile injectable formulation requires attention to manufacturing controls, documentation, packaging integrity, storage conditions, and regulatory requirements. Taj Medico positions its Colistimethate Sodium for Injection I.P. 2 MIU Supplier services around these procurement requirements.
Why Quality Manufacturing Matters for Critical-Care Antibiotics
The quality of an injectable medicine depends on more than testing the finished product. Manufacturing controls, validated processes, appropriate environmental controls, qualified raw materials, packaging systems, documentation, and quality-control procedures all contribute to product consistency.
WHO describes GMP as a quality-assurance system designed to ensure that medicinal products are consistently produced and controlled according to appropriate quality standards.
For sterile pharmaceutical products, manufacturing controls are particularly important because contamination and other manufacturing failures can present serious risks. Buyers should therefore evaluate the manufacturer’s quality systems, regulatory documentation, manufacturing authorization, and product-specific compliance before placing an order.
Colistimethate Sodium for Injection I.P. 2 MIU for Importers and Exporters
International pharmaceutical procurement requires more than simply purchasing a finished product. Importers and distributors commonly require product information, commercial documentation, quality documentation, shipping information, and regulatory support appropriate to the destination market.
Regulatory Documentation
Depending on the destination country and registration pathway, Taj Medico can coordinate relevant pharmaceutical documentation as applicable to the product and market. Documentation requirements may include:
- Certificate of Analysis (CoA)
- Certificate of Pharmaceutical Product (COPP), where applicable
- Manufacturing and product information
- Product specifications
- Stability information
- Packaging details
- Batch-related quality documents
- Regulatory declarations
- CTD/eCTD dossier components where applicable
- Export and commercial documentation
Actual documentation availability depends on the product, destination country, registration requirements, and applicable regulatory authority.
Custom Packaging and Labeling
Pharmaceutical buyers may have different requirements for packaging and labeling depending on their market. Product presentation can be coordinated according to applicable regulatory and commercial specifications, including product name, strength, batch information, manufacturing information, expiry information, storage conditions, and other legally required particulars.
Proper packaging is particularly important for injectable medicines because it helps protect the product during storage, transportation, handling, and distribution.
Shelf Life, Storage, and Dosage Form
Dosage form: Sterile powder for injection, subject to the approved product presentation.
Strength: 2 MIU per vial, as specified for the product.
Administration: Parenteral administration by qualified healthcare professionals.
Storage: Follow the approved product label and manufacturer’s storage instructions.
Shelf life: Refer to the product-specific packaging and approved stability information.
Healthcare professionals should follow the approved prescribing information for preparation, dilution, administration, dosing, contraindications, warnings, and monitoring.
Export Certifications and Regulatory Support
International buyers may request regulatory documents such as WHO-GMP-related documentation, COPP, CTD dossier information, manufacturing licenses, certificates of analysis, stability data, and other country-specific documents. The exact certification package varies by destination and regulatory pathway.
WHO notes that GMP supports consistent pharmaceutical production and quality control, while national regulatory authorities may establish additional requirements for manufacturing and marketing authorization.
Therefore, buyers should confirm the precise regulatory requirements applicable in their country before importing or registering Colistimethate Sodium for Injection I.P. 2 MIU.
Target Export Markets
India | Vietnam | UAE | Saudi Arabia | Kenya | Tanzania | Nigeria | Philippines | Cambodia | Ghana | Peru | Colombia | Uzbekistan | Kazakhstan | Sri Lanka | Myanmar | Yemen | Oman | South Africa | Chile
Why Taj Medico is a Trusted Manufacturer and Supplier
State-of-the-Art Manufacturing Approach
Taj Medico is presented as an established Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection I.P. 2 MIU from Vapi, Gujarat, India. Its pharmaceutical manufacturing approach emphasizes controlled production, quality assurance, testing, documentation, and supply consistency.
For critical-care products, dependable manufacturing is particularly important because buyers need confidence in product specifications and batch-to-batch consistency.
Affordable Pricing and Quality Assurance
Cost competitiveness is an important consideration for pharmaceutical distributors and institutional procurement teams. Taj Medico aims to combine competitive commercial terms with quality-focused manufacturing and documented product specifications.
However, the lowest purchase price should not be the only procurement criterion. Buyers should also evaluate quality systems, regulatory compliance, documentation, packaging, lead time, logistics, and after-sales support.
Global Supply Chain Support
International pharmaceutical supply requires coordinated communication between manufacturer, exporter, freight partners, importers, distributors, and regulatory stakeholders. Taj Medico can support buyer inquiries concerning quantities, packaging requirements, commercial documentation, and export coordination, subject to the destination country’s requirements.
Colistimethate Sodium for Injection I.P. 2 MIU – Technical Product Specification
| Parameter | Specification |
|---|---|
| Product Name | Colistimethate Sodium for Injection I.P. 2 MIU |
| Active Ingredient | Colistimethate Sodium |
| Strength | 2 MIU |
| Dosage Form | Sterile powder for injection |
| Therapeutic Category | Antibacterial |
| Primary Use | Severe bacterial infections caused by susceptible organisms |
| Route | Parenteral administration under healthcare supervision |
| Packaging | Vial-based presentation, subject to approved pack |
| Storage | As stated on approved product labeling |
| Shelf Life | As stated on product packaging/approved stability data |
| Target Buyers | Importers, distributors, hospitals and pharmaceutical companies |
| Manufacturing Location | Vapi, Gujarat, India |
| Export Documentation | Available according to product and destination requirements |
Safety and Responsible Use
Colistimethate sodium should only be used under appropriate medical supervision. Potential adverse effects can include neurological effects and kidney-related toxicity, among other reactions. Patients with impaired renal function may require dose adjustment and appropriate monitoring.
Patients should inform their healthcare professional about existing kidney problems, allergies, pregnancy, breastfeeding, and other medicines being taken. Treatment should be administered according to the prescribing healthcare professional’s instructions.
The information on this page is intended for pharmaceutical procurement and general educational purposes and should not replace professional medical advice or approved prescribing information.
Colistimethate Sodium for Injection I.P. 2 MIU PAN India Manufacturer and Supplier
Taj Medico serves buyers looking for a Colistimethate Sodium for Injection I.P. 2 MIU PAN India Manufacturer, supplier, and export partner. Its location in Vapi, Gujarat, provides a strategic base for pharmaceutical manufacturing and distribution activities.
The company can cater to inquiries involving domestic supply, institutional procurement, international distribution, and pharmaceutical export requirements, subject to applicable regulations and product availability.
Colistimethate Sodium for Injection I.P. 2 MIU Manufacturer Supplier and PCD Pharma Franchise
Pharmaceutical companies and distributors interested in adding critical-care injectable products to their portfolios can contact Taj Medico to discuss commercial opportunities. PCD or franchise arrangements, where offered, should be evaluated according to the applicable territory, product registration, licensing requirements, minimum order quantities, and commercial terms.
Colistimethate Sodium for Injection I.P. 2 MIU Manufacturer from Vapi, Gujarat
Vapi is an established pharmaceutical and industrial location in Gujarat. Taj Medico’s manufacturing and supply activities from Vapi support its positioning as an Indian pharmaceutical exporter.
For buyers searching for Colistimethate Sodium for Injection I.P. 2 MIU Manufacturer Vapi, Gujarat, selecting a supplier should involve verification of manufacturing credentials, product documentation, quality standards, regulatory suitability, and supply capabilities.
Frequently Asked Questions
1. What is Colistimethate Sodium for Injection I.P. 2 MIU?
It is a sterile injectable antibacterial medicine containing colistimethate sodium at a strength of 2 MIU per specified vial presentation.
2. What is Colistimethate Sodium used for?
It is used under medical supervision for serious infections caused by susceptible Gram-negative bacteria, particularly where treatment options may be limited.
3. Who should administer Colistimethate Sodium Injection?
It should be prepared and administered by appropriately qualified healthcare professionals.
4. Can patients self-administer this injection?
No. Injectable colistimethate sodium should not be self-administered unless specifically directed and managed within an appropriate clinical setting.
5. Is Colistimethate Sodium used for multidrug-resistant infections?
It may be used for certain serious infections involving susceptible multidrug-resistant Gram-negative bacteria when clinically appropriate.
6. What does 2 MIU mean?
MIU means million international units. The stated strength is 2 million international units for the product presentation.
7. Who is a Colistimethate Sodium for Injection I.P. 2 MIU manufacturer in India?
Taj Medico is presented as a manufacturer, exporter, and supplier of Colistimethate Sodium for Injection I.P. 2 MIU from Vapi, Gujarat, India.
8. Does Taj Medico export Colistimethate Sodium Injection?
Taj Medico supports pharmaceutical export inquiries, subject to product availability, destination-country regulations, registration requirements, and applicable export documentation.
9. What documents can pharmaceutical buyers request?
Depending on the market, buyers may request CoA, product specifications, stability information, manufacturing documents, COPP and CTD dossier components where applicable.
10. Does Taj Medico provide customized packaging?
Packaging and labeling requirements can be discussed according to the applicable regulatory and commercial specifications of the destination market.
11. What is the shelf life of the product?
The exact shelf life should be confirmed from the current product specification, approved stability data, and product packaging.
12. How should the product be stored?
Storage should follow the manufacturer’s approved label and product-specific instructions.
13. Can Colistimethate Sodium affect the kidneys?
Yes. Kidney-related toxicity is an important safety consideration, and healthcare professionals may monitor renal function during treatment.
14. Can Colistimethate Sodium cause neurological side effects?
Neurological adverse effects can occur. Patients should report unusual neurological symptoms to their healthcare professional.
15. Is Colistimethate Sodium suitable during pregnancy?
Pregnant or breastfeeding patients should consult a qualified healthcare professional before treatment.
16. What markets can import Colistimethate Sodium from India?
Import eligibility varies by country. African, Middle Eastern, Asian, and other international markets may have specific registration and import requirements.
17. What is a WHO-GMP manufacturer?
A manufacturer operating under applicable GMP requirements follows documented systems intended to ensure consistent pharmaceutical production and quality control. Specific certification claims should be verified for the individual facility and product.
18. Can buyers request bulk quantities?
Importers, distributors, and institutional buyers can contact Taj Medico regarding quantities, availability, packaging, and commercial terms.
19. Can Taj Medico support CTD dossier requirements?
CTD-related documentation may be available depending on the product and market. Buyers should specify their country’s registration requirements when making an inquiry.
20. How can international buyers contact Taj Medico?
Buyers and distributors can contact Taj Medico with their required quantity, destination country, packaging requirements, and regulatory documentation needs to discuss supply possibilities.
Choosing the right Colistimethate Sodium for Injection I.P. 2 MIU Manufacturer in India requires careful consideration of quality, regulatory documentation, manufacturing capabilities, packaging, supply reliability, and export support. Taj Medico, based in Vapi, Gujarat, India, offers itself as a manufacturer, exporter, and supplier for buyers seeking this critical-care injectable product.
For international procurement, buyers should communicate their destination market, required quantity, packaging preference, registration status, and documentation requirements. This allows the supply process to be aligned with the applicable regulatory and commercial conditions.






